Related Experiment Video
Updated: May 29, 2026

04:55
A Simple Mechanical Procedure to Create Limbal Stem Cell Deficiency in Mouse
Published on: November 17, 2016
[Perspectives and current state in limbal stem cell transplantation]
1Universitäts-Augenklinik Freiburg, Killianstr. 5, 79106, Freiburg, Deutschland. philipp.eberwein@uniklinik-freiburg.de
Summary
Limbal stem cell transplantation treats ocular surface diseases. Research explores new methods like hair follicle stem cells and optimizing the limbal stem cell niche for better treatments.
Area of Science:
- Ophthalmology
- Regenerative Medicine
- Stem Cell Biology
Context:
- Ocular surface reconstruction relies heavily on limbal stem cell transplantation.
- Limbal stem cell insufficiency (LSCI) presents challenges in treating corneal diseases.
- Current treatments for LSCI range from surgical interventions to ex vivo cell expansion.
Purpose:
- To review current and emerging strategies for limbal stem cell transplantation in ocular surface reconstruction.
- To evaluate the efficacy and limitations of various LSCI treatment modalities.
- To explore novel approaches, including stem cell transdifferentiation and niche optimization.
Summary:
- Autologous transplantation and ex vivo expansion are options for partial LSCI, while complete bilateral LSCI necessitates allogeneic transplantation with immunological risks.
- Combining allogeneic transplantation with mitomycin C and amniotic membrane shows promise.
- Transdifferentiation of hair follicle stem cells into corneal epithelial cells is a promising avenue, unlike bone marrow stem cells.
- Research into the limbal stem cell niche aims to improve ex vivo culture conditions.
Impact:
- Advances in limbal stem cell therapy can significantly improve outcomes for patients with severe ocular surface diseases.
- Developing safer and more effective transplantation methods reduces the risk of immune rejection.
- Understanding the stem cell niche may lead to innovative regenerative therapies for corneal regeneration.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
Forced Transdifferentiation
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial transdifferentiation occurs...
Artificial transdifferentiation occurs...

